Aptamers show promise as diagnostic and therapeutic tools for rheumatic diseases, with potential for both diagnostic assays and targeted therapies.

Aptamers can replace antibodies in clinical diagnostics due to their superior specificity, sensitivity, and reproducibility, along with their potential for rapid, cost-effective detection with minimal procedural changes.

Nucleic acid aptamers show promise in cancer research due to their specificity, stability, and versatility in binding to target molecules, contributing to biomarker discovery, diagnosis, and therapy.